[HTML][HTML] Efficacy and safety of combined brain radiotherapy and immunotherapy in non-small-cell lung cancer with brain metastases: a systematic review and meta …
Y Yang, L Deng, Y Yang, T Zhang, Y Wu, L Wang… - Clinical Lung Cancer, 2022 - Elsevier
Abstract Background: Immune checkpoint inhibitors (ICIs) are recommended to treat
advanced non-small cell lung cancer (NSCLC), whereas brain radiotherapy (RT) is the …
advanced non-small cell lung cancer (NSCLC), whereas brain radiotherapy (RT) is the …
[HTML][HTML] International consensus on radiotherapy in metastatic non-small cell lung cancer
Z Zhu, J Ni, X Cai, S Su, H Zhuang, Z Yang… - Translational Lung …, 2022 - ncbi.nlm.nih.gov
Background Lung cancer is the leading cause of cancer-related death worldwide, with non-
small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has …
small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has …
Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)
S Gill, AK Nowak, S Bowyer, R Endersby… - Journal of Medical …, 2022 - Wiley Online Library
Previous preclinical and clinical trials have shown promising antitumour activity and toxicity
profile when employing the 'Synergy between Immunotherapy and Radiotherapy'(SITAR) …
profile when employing the 'Synergy between Immunotherapy and Radiotherapy'(SITAR) …
[HTML][HTML] 放疗联合免疫治疗对肺癌脑转移的疗效和安全性的meta 分析
徐利娟， 陈应泰， 王梅 - Chinese Journal of Lung Cancer, 2022 - ncbi.nlm.nih.gov
背景与目的免疫治疗(immunotherapy, IT) 被推荐用于治疗晚期非小细胞肺癌(non-small cell
lung cancer, NSCLC), 而脑放疗(radiation therapy, RT) 是脑转移(brain metastasis, BM) …
lung cancer, NSCLC), 而脑放疗(radiation therapy, RT) 是脑转移(brain metastasis, BM) …
Efficacy and safety of combined brain stereotactic radiotherapy and immune checkpoint inhibitors in non-small-cell lung cancer with brain metastases
J Porte, C Saint-Martin, T Frederic-Moreau… - Biomedicines, 2022 - mdpi.com
Background: To analyze the outcomes of patients with brain metastases (BM) from non-
small cell lung cancer (NSCLC) treated with immunotherapy (IT) and stereotactic …
small cell lung cancer (NSCLC) treated with immunotherapy (IT) and stereotactic …
A survival score for very elderly patients with brain metastases assigned to stereotactic radiosurgery or fractionated stereotactic radiotherapy
D Rades, C Delikanli, O Blanck, SE Schild… - Anticancer …, 2022 - ar.iiarjournals.org
Abstract Background/Aim: Very elderly patients may benefit from individualized treatment. A
survival score was created for patients aged 80+ receiving radiosurgery or fractionated …
survival score was created for patients aged 80+ receiving radiosurgery or fractionated …
The dosimetric parameters impact on local recurrence in stereotactic radiotherapy for brain metastases
C Berthet, F Lucia, V Bourbonne… - British Journal of …, 2024 - academic.oup.com
Objectives Stereotactic radiotherapy (SRT) for brain metastases (BM) allows very good local
control (LC). However, approximately 20%-30% of these lesions will recur. The objective of …
control (LC). However, approximately 20%-30% of these lesions will recur. The objective of …
Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade
KM Kraus, JC Fischer, KJ Borm, MME Vogel… - Scientific reports, 2021 - nature.com
The results of this survey reveal current clinical practice in the handling of combined
radioimmunotherapy with Immune Checkpoint Inhibitors (RT+ ICI). We aim to provide a …
radioimmunotherapy with Immune Checkpoint Inhibitors (RT+ ICI). We aim to provide a …
[HTML][HTML] Global research landscape and trends of cancer radiotherapy plus immunotherapy: A bibliometric analysis
Y Liu, X Jiang, Y Wu, H Yu - Heliyon, 2024 - cell.com
The aim of this study was to present current research trends on the synergistic use of
radiotherapy and immunotherapy (IRT) for cancer treatment. On March 1, 2023, we …
radiotherapy and immunotherapy (IRT) for cancer treatment. On March 1, 2023, we …
The Safety and Efficacy of Concurrent Immune Checkpoint Blockade and Stereotactic Radiosurgery Therapy with Practitioner and Researcher Recommendations
Y Mehkri, SA Windermere, MEH Still, SC Yan… - World Neurosurgery, 2023 - Elsevier
Background Immune checkpoint inhibitors (ICIs) have shown growing promise in the
treatment of brain metastases, especially combined with stereotactic radiosurgery (SRS) …
treatment of brain metastases, especially combined with stereotactic radiosurgery (SRS) …